| Dr Molly Joan King -gove, OD | |
|
468 Hospital Dr, St Johnsbury, VT 05819-9225 | |
| (802) 223-7723 | |
| Not Available |
| Full Name | Dr Molly Joan King -gove |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 7 Years |
| Location | 468 Hospital Dr, St Johnsbury, Vermont |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548780133 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Shippee Family Eye Care, P.c. | 4183772239 | 10 |
News Archive
More than six out of 10 Virginia voters support an expansion of Medicaid benefits to cover the estimated 400,000 state residents in the coverage gap, according to a new survey released on the eve of a special session of the Virginia General Assembly to discuss the issue. But nearly half of Virginians surveyed have doubts that the federal government would fully fund its share of the program, according to the poll, conducted by the Wason Center for Public Policy at Christopher Newport University (Nolan, 9/17).
Breast cancer represents about a fifth of all cancers diagnosed in women. The reasons for the rapid progression of the disease remain relatively poorly understood but recent work in the group of Veronika Sexl at the University of Veterinary Medicine, Vienna has pointed the finger strongly at loss or inactivation of the transcription factor STAT1.
Gerard Malanga, MD, and Nathan Hogaboom, PhD, of Kessler Foundation received a $185,707 award from The Geneva Foundation (Geneva) to study factors contributing to the development of osteoarthritis following acute knee injuries, a common disabling condition among active-duty military personnel.
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, has received approval from the U.S. Food and Drug Administration for Ortho's VITROS Immunodiagnostic Products HBeAg Assay and the VITROS Immunodiagnostic Products Anti-HBe Assay for use on Ortho's VITROS 3600 Immunodiagnostic System and Ortho's VITROS 5600 Integrated System.
Valerion Therapeutics, LLC yesterday announced positive results from a non-clinical "proof of concept" pilot study for a novel humanized antibody and acid alpha glucosidase (GAA) fusion candidate for the treatment of Pompe disease.
› Verified 8 days ago
| Provider Name | Shippee Family Eye Care, P.c. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1023407467 PECOS PAC ID: 4183772239 Enrollment ID: O20150515000060 |
News Archive
More than six out of 10 Virginia voters support an expansion of Medicaid benefits to cover the estimated 400,000 state residents in the coverage gap, according to a new survey released on the eve of a special session of the Virginia General Assembly to discuss the issue. But nearly half of Virginians surveyed have doubts that the federal government would fully fund its share of the program, according to the poll, conducted by the Wason Center for Public Policy at Christopher Newport University (Nolan, 9/17).
Breast cancer represents about a fifth of all cancers diagnosed in women. The reasons for the rapid progression of the disease remain relatively poorly understood but recent work in the group of Veronika Sexl at the University of Veterinary Medicine, Vienna has pointed the finger strongly at loss or inactivation of the transcription factor STAT1.
Gerard Malanga, MD, and Nathan Hogaboom, PhD, of Kessler Foundation received a $185,707 award from The Geneva Foundation (Geneva) to study factors contributing to the development of osteoarthritis following acute knee injuries, a common disabling condition among active-duty military personnel.
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, has received approval from the U.S. Food and Drug Administration for Ortho's VITROS Immunodiagnostic Products HBeAg Assay and the VITROS Immunodiagnostic Products Anti-HBe Assay for use on Ortho's VITROS 3600 Immunodiagnostic System and Ortho's VITROS 5600 Integrated System.
Valerion Therapeutics, LLC yesterday announced positive results from a non-clinical "proof of concept" pilot study for a novel humanized antibody and acid alpha glucosidase (GAA) fusion candidate for the treatment of Pompe disease.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Molly Joan King -gove, OD 40 Rockingham Ave Apt 204, West Roxbury, MA 02132-4523 Ph: (908) 268-6480 | Dr Molly Joan King -gove, OD 468 Hospital Dr, St Johnsbury, VT 05819-9225 Ph: (802) 223-7723 |
News Archive
More than six out of 10 Virginia voters support an expansion of Medicaid benefits to cover the estimated 400,000 state residents in the coverage gap, according to a new survey released on the eve of a special session of the Virginia General Assembly to discuss the issue. But nearly half of Virginians surveyed have doubts that the federal government would fully fund its share of the program, according to the poll, conducted by the Wason Center for Public Policy at Christopher Newport University (Nolan, 9/17).
Breast cancer represents about a fifth of all cancers diagnosed in women. The reasons for the rapid progression of the disease remain relatively poorly understood but recent work in the group of Veronika Sexl at the University of Veterinary Medicine, Vienna has pointed the finger strongly at loss or inactivation of the transcription factor STAT1.
Gerard Malanga, MD, and Nathan Hogaboom, PhD, of Kessler Foundation received a $185,707 award from The Geneva Foundation (Geneva) to study factors contributing to the development of osteoarthritis following acute knee injuries, a common disabling condition among active-duty military personnel.
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, has received approval from the U.S. Food and Drug Administration for Ortho's VITROS Immunodiagnostic Products HBeAg Assay and the VITROS Immunodiagnostic Products Anti-HBe Assay for use on Ortho's VITROS 3600 Immunodiagnostic System and Ortho's VITROS 5600 Integrated System.
Valerion Therapeutics, LLC yesterday announced positive results from a non-clinical "proof of concept" pilot study for a novel humanized antibody and acid alpha glucosidase (GAA) fusion candidate for the treatment of Pompe disease.
› Verified 8 days ago
Dba Optical Expressions Optometrist Medicare: Medicare Enrolled Practice Location: 468 Hospital Dr, St Johnsbury, VT 05819 Phone: 802-748-3536 Fax: 802-748-4838 | |
Optical Expressions, Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2000 Memorial Dr, Suite 6, St Johnsbury, VT 05819 Phone: 802-748-3536 Fax: 802-748-4838 | |
Dr. Stephen A Feltus, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2000 Memorial Dr, Suite 6, St Johnsbury, VT 05819 Phone: 802-748-3536 Fax: 802-748-4838 | |
Erica Michelle Guelette, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 468 Hospital Dr, St Johnsbury, VT 05819 Phone: 802-748-3536 | |
Julia Kitchens, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 468 Hospital Dr, St Johnsbury, VT 05819 Phone: 802-748-3536 Fax: 802-748-4838 | |
Dr. Jennifer Lyn Boggie, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 468 Hospital Dr, St Johnsbury, VT 05819 Phone: 802-748-3536 Fax: 802-748-4838 | |
Brian J Mawhinney, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1290 Hospital Dr, Suite 5, St Johnsbury, VT 05819 Phone: 802-748-8126 Fax: 802-748-2208 |